As genome editing rapidly progresses toward the realization of its clinical promise, assessing the suitability of current tools and processes used for its benefit-risk assessment is critical. Although current regulations may initially provide an adequate regulatory framework, improvements are recommended to overcome several existing technology-based safety and efficacy issues.

中文翻译：

---

诊所中的人类基因组编辑：监管利益风险评估中的新挑战。

随着基因组编辑朝着实现其临床前景迅速发展，评估当前用于其利益风险评估的工具和过程的适用性至关重要。尽管当前的法规最初可能会提供适当的法规框架，但建议进行改进以克服一些现有的基于技术的安全性和有效性问题。